Our industry is constantly evolving and increasingly complicated. Our biopharmaceutical clients struggle with conflicting news, insufficient information sources, and an array of challenges needing diverse solutions for each customer group.
What we do
- Prioritize the most important oncology market access trends and implications as they evolve
- Decipher complexities by engaging with the most knowledgeable customers and decision-makers
- Directly support annual brand planning and launch strategic/brand plan launches, account engagement, and tailored customer communications
What we offer
- Syndicated Market Studies featuring primary and secondary research with high-quality input and in-depth, informed analytics
- Report readout discussions with each subscriber team multiple times per year
- Proprietary customer archetypes that enable clients to quickly understand and plan for different types of IDNs, payers, and community oncology groups
- Insights Summaries specifically designed to support annual brand planning and launch planning
- Client inquiry hours that help clients apply insights to specific business challenges and opportunities and to take advantage of our direct professional experience
- Data set training and ongoing support
We obsess over helping our clients understand the developments that are real and impactful, versus passing fads that distract.
Lee Blansett
Executive Vice President